{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:14:25Z","timestamp":1789913665542,"version":"4.0.1"},"reference-count":81,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2014.00260","type":"journal-article","created":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T09:14:49Z","timestamp":1402391689000},"source":"Crossref","is-referenced-by-count":24,"title":["Leishmania spp. Proteome Data Sets: A Comprehensive Resource for Vaccine Development to Target Visceral Leishmaniasis"],"prefix":"10.3389","volume":"5","author":[{"given":"Toni","family":"Aebischer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2014,6,10]]},"reference":[{"issue":"26","key":"B1","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1016\/j.vaccine.2012.03.068","article-title":"Leishmaniasis: vaccine candidates and perspectives","volume":"30","author":"Singh","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"B2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4103\/0974-777X.62881","article-title":"Leishmaniasis vaccine: where are we today?","volume":"2","author":"Kedzierski","year":"2010","journal-title":"J Glob Infect Dis"},{"issue":"2","key":"B3","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1371\/journal.pntd.0000114","article-title":"Measuring the burden of neglected tropical diseases: the global burden of disease framework","volume":"1","author":"Mathers","year":"2007","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"B4","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S1473-3099(05)70296-6","article-title":"Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004","volume":"5","author":"Olliaro","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"B5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.4269\/ajtmh.2012.10-0415","article-title":"The economic value of a visceral leishmaniasis vaccine in Bihar state, India","volume":"86","author":"Lee","year":"2012","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"B6","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.mib.2012.05.002","article-title":"Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives","volume":"15","author":"Fernandes","year":"2012","journal-title":"Curr Opin Microbiol"},{"issue":"8","key":"B7","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.4049\/jimmunol.168.8.3992","article-title":"CD8+ T cells are required for primary immunity in C57BL\/6 mice following low-dose, intradermal challenge with Leishmania major","volume":"168","author":"Belkaid","year":"2002","journal-title":"J Immunol"},{"issue":"2","key":"B8","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/infdis\/jit401","article-title":"CD8 T cell exhaustion in human visceral leishmaniasis","volume":"209","author":"Gautam","year":"2014","journal-title":"J Infect Dis"},{"issue":"4","key":"B9","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1084\/jem.20061141","article-title":"Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis","volume":"204","author":"Nylen","year":"2007","journal-title":"J Exp Med"},{"issue":"11","key":"B10","doi-asserted-by":"publisher","first-page":"e1405","DOI":"10.1371\/journal.pntd.0001405","article-title":"Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and control","volume":"5","author":"Stauch","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"B11","doi-asserted-by":"publisher","first-page":"e1284","DOI":"10.1371\/journal.pntd.0001284","article-title":"Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study","volume":"5","author":"Ostyn","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"B12","first-page":"377","article-title":"Effectiveness of leishmanization in the control of cutaneous leishmaniasis","volume":"76","author":"Nadim","year":"1983","journal-title":"Bull Soc Pathol Exot Filiales"},{"issue":"1\u00e2\u20ac\u201c2","key":"B13","first-page":"240","article-title":"Characterization of Leishmania isolated from unhealed lesions caused by leishmanization","volume":"11","author":"Hosseini","year":"2005","journal-title":"East Mediterr Health J"},{"issue":"28","key":"B14","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1016\/j.vaccine.2005.02.015","article-title":"Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis","volume":"23","author":"Khamesipour","year":"2005","journal-title":"Vaccine"},{"issue":"5","key":"B15","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.4049\/jimmunol.1202801","article-title":"Live attenuated Leishmania donovani p27 gene knockout parasites are nonpathogenic and elicit long-term protective immunity in BALB\/c mice","volume":"190","author":"Dey","year":"2013","journal-title":"J Immunol"},{"issue":"6","key":"B16","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.1128\/IAI.72.6.3622-3627.2004","article-title":"Identification of a compensatory mutant (lpg2-REV) of Leishmania major able to survive as amastigotes within macrophages without LPG2-dependent glycoconjugates and its significance to virulence and immunization strategies","volume":"72","author":"Spath","year":"2004","journal-title":"Infect Immun"},{"issue":"22","key":"B17","doi-asserted-by":"publisher","first-page":"10267","DOI":"10.1073\/pnas.92.22.10267","article-title":"Development of a safe live Leishmania vaccine line by gene replacement","volume":"92","author":"Titus","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"B18","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.vaccine.2013.01.048","article-title":"Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs","volume":"31","author":"Fiuza","year":"2013","journal-title":"Vaccine"},{"key":"B19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3389\/fimmu.2014.00134","article-title":"Live vaccination tactics: possible approaches for controlling visceral leishmaniasis","volume":"5","author":"Saljoughian","year":"2014","journal-title":"Front Immunol"},{"issue":"5","key":"B20","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.pt.2005.03.006","article-title":"Second-generation vaccines against leishmaniasis","volume":"21","author":"Coler","year":"2005","journal-title":"Trends Parasitol"},{"issue":"7","key":"B21","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1084\/jem.20092532","article-title":"IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform","volume":"207","author":"Darrah","year":"2010","journal-title":"J Exp Med"},{"issue":"5","key":"B22","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/infdis\/jir842","article-title":"Therapeutic vaccination with recombinant adenovirus reduces splenic parasite burden in experimental visceral leishmaniasis","volume":"205","author":"Maroof","year":"2012","journal-title":"J Infect Dis"},{"issue":"7","key":"B23","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.4049\/jimmunol.145.7.2281","article-title":"Oral Salmonella typhimurium (AroA\u00e2\u02c6\u2019) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis","volume":"145","author":"Yang","year":"1990","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4161\/hv.7.0.14556","article-title":"Vaccines for leishmaniasis: from proteome to vaccine candidates","volume":"7","author":"Schroeder","year":"2011","journal-title":"Hum Vaccin"},{"issue":"6","key":"B25","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1128\/CVI.00143-12","article-title":"Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood","volume":"19","author":"Singh","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"B26","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S1369-5274(00)00119-3","article-title":"Reverse vaccinology","volume":"3","author":"Rappuoli","year":"2000","journal-title":"Curr Opin Microbiol"},{"issue":"5459","key":"B27","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"issue":"5","key":"B28","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1007\/s12010-012-9649-0","article-title":"A reverse vaccinology approach for the identification of potential vaccine candidates from Leishmania spp","volume":"167","author":"John","year":"2012","journal-title":"Appl Biochem Biotechnol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/1471-2105-13-309","article-title":"An assessment on epitope prediction methods for protozoa genomes","volume":"13","author":"Resende","year":"2012","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"B30","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/pmic.200800533","article-title":"Mining the Leishmania genome for novel antigens and vaccine candidates","volume":"9","author":"Herrera-Najera","year":"2009","journal-title":"Proteomics"},{"issue":"2","key":"B31","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00436-007-0491-1","article-title":"Selection of endogenous reference genes for gene expression analysis in Leishmania major developmental stages","volume":"101","author":"Ouakad","year":"2007","journal-title":"Parasitol Res"},{"issue":"11","key":"B32","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1016\/j.molimm.2008.02.019","article-title":"Leishmania initially activates but subsequently down-regulates intracellular mitogen-activated protein kinases and nuclear factor-kappaB signaling in macrophages","volume":"45","author":"Ben-Othman","year":"2008","journal-title":"Mol Immunol"},{"issue":"3","key":"B33","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1128\/IAI.58.3.779-787.1990","article-title":"Parasitophorous vacuoles of Leishmania amazonensis-infected macrophages maintain an acidic pH","volume":"58","author":"Antoine","year":"1990","journal-title":"Infect Immun"},{"key":"B34","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1242\/jcs.115.11.2303","article-title":"Biogenesis of Leishmania-harbouring parasitophorous vacuoles following phagocytosis of the metacyclic promastigote or amastigote stages of the parasites","volume":"115","author":"Courret","year":"2002","journal-title":"J Cell Sci"},{"issue":"12","key":"B35","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/S0020-7519(01)00259-4","article-title":"Life in vacuoles \u00e2\u20ac\u201c nutrient acquisition by Leishmania amastigotes","volume":"31","author":"Burchmore","year":"2001","journal-title":"Int J Parasitol"},{"issue":"Pt 2","key":"B36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1242\/jcs.110.2.191","article-title":"Transfer of phagocytosed particles to the parasitophorous vacuole of Leishmania mexicana is a transient phenomenon preceding the acquisition of annexin I by the phagosome","volume":"110","author":"Collins","year":"1997","journal-title":"J Cell Sci"},{"issue":"10","key":"B37","doi-asserted-by":"publisher","first-page":"e1001154","DOI":"10.1371\/journal.ppat.1001154","article-title":"Visualization of peptide\/MHC complexes at the surface and in the intracellular compartments of cells infected in vivo by Leishmania major","volume":"6","author":"Muraille","year":"2010","journal-title":"PLoS Pathog"},{"issue":"6","key":"B38","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1189\/jlb.0611326","article-title":"Secreted virulence factors and immune evasion in visceral leishmaniasis","volume":"91","author":"Lambertz","year":"2012","journal-title":"J Leukoc Biol"},{"issue":"9","key":"B39","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.4049\/jimmunol.1000541","article-title":"Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells","volume":"185","author":"Silverman","year":"2010","journal-title":"J Immunol"},{"issue":"12","key":"B40","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1002\/eji.1830261248","article-title":"Antigen presentation by Leishmania mexicana-infected macrophages: activation of helper T cells by a model parasite antigen secreted into the parasitophorous vacuole or expressed on the amastigote surface","volume":"26","author":"Wolfram","year":"1996","journal-title":"Eur J Immunol"},{"issue":"6","key":"B41","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.4049\/jimmunol.177.6.3525","article-title":"Leishmania antigens are presented to CD8+ T cells by a transporter associated with antigen processing-independent pathway in vitro and in vivo","volume":"177","author":"Bertholet","year":"2006","journal-title":"J Immunol"},{"issue":"8","key":"B42","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.4049\/jimmunol.176.8.4826","article-title":"In vivo recognition of ovalbumin expressed by transgenic Leishmania is determined by its subcellular localization","volume":"176","author":"Prickett","year":"2006","journal-title":"J Immunol"},{"issue":"10","key":"B43","doi-asserted-by":"publisher","first-page":"6620","DOI":"10.1128\/IAI.73.10.6620-6628.2005","article-title":"Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells","volume":"73","author":"Bertholet","year":"2005","journal-title":"Infect Immun"},{"issue":"3","key":"B44","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/eji.200324391","article-title":"Two waves of antigen-containing dendritic cells in vivo in experimental Leishmania major infection","volume":"34","author":"Misslitz","year":"2004","journal-title":"Eur J Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fmicb.2012.00074","article-title":"Characteristics of \u00e2\u20ac\u0153Tip-DCs and MDSCs\u00e2\u20ac\u009d and their potential role in leishmaniasis","volume":"3","author":"Schmid","year":"2012","journal-title":"Front Microbiol"},{"issue":"1","key":"B46","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.chom.2009.04.014","article-title":"A dynamic map of antigen recognition by CD4 T cells at the site of Leishmania major infection","volume":"6","author":"Filipe-Santos","year":"2009","journal-title":"Cell Host Microbe"},{"issue":"1","key":"B47","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.immuni.2012.05.015","article-title":"CD4+ T cells rely on a cytokine gradient to control intracellular pathogens beyond sites of antigen presentation","volume":"37","author":"Muller","year":"2012","journal-title":"Immunity"},{"issue":"4","key":"B48","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/eji.1830250435","article-title":"Antigen presentation by Leishmania mexicana-infected macrophages: activation of helper T cells specific for amastigote cysteine proteinases requires intracellular killing of the parasites","volume":"25","author":"Wolfram","year":"1995","journal-title":"Eur J Immunol"},{"issue":"3","key":"B49","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/(SICI)1521-4141(199903)29:03762::AID-IMMU7623.0.CO;2-4","article-title":"Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites","volume":"29","author":"Courret","year":"1999","journal-title":"Eur J Immunol"},{"issue":"6","key":"B50","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1084\/jem.191.6.927","article-title":"The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli","volume":"191","author":"Inaba","year":"2000","journal-title":"J Exp Med"},{"issue":"26","key":"B51","doi-asserted-by":"publisher","first-page":"15050","DOI":"10.1073\/pnas.96.26.15050","article-title":"Abundant empty class II MHC molecules on the surface of immature dendritic cells","volume":"96","author":"Santambrogio","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6644","key":"B52","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/42039","article-title":"Developmental regulation of MHC class II transport in mouse dendritic cells","volume":"388","author":"Pierre","year":"1997","journal-title":"Nature"},{"issue":"12","key":"B53","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/nri1250","article-title":"Making sense of mass destruction: quantitating MHC class I antigen presentation","volume":"3","author":"Yewdell","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"B54","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1084\/jem.20021542","article-title":"Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation","volume":"198","author":"Delamarre","year":"2003","journal-title":"J Exp Med"},{"issue":"9","key":"B55","doi-asserted-by":"publisher","first-page":"4869","DOI":"10.4049\/jimmunol.167.9.4869","article-title":"Stability of surface H-2K(b), H-2D(b), and peptide-receptive H-2K(b) on splenocytes","volume":"167","author":"Su","year":"2001","journal-title":"J Immunol"},{"issue":"6","key":"B56","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S1074-7613(00)80483-5","article-title":"Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response","volume":"4","author":"Sykulev","year":"1996","journal-title":"Immunity"},{"issue":"12","key":"B57","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1002\/eji.1830271230","article-title":"The minimal number of antigen-major histocompatibility complex class II complexes required for activation of naive and primed T cells","volume":"27","author":"Kimachi","year":"1997","journal-title":"Eur J Immunol"},{"issue":"22","key":"B58","doi-asserted-by":"publisher","first-page":"9089","DOI":"10.1073\/pnas.1018771108","article-title":"T-cell triggering thresholds are modulated by the number of antigen within individual T-cell receptor clusters","volume":"108","author":"Manz","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"B59","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0169-4758(99)01473-8","article-title":"Antigen presentation by macrophages harboring intravesicular pathogens","volume":"15","author":"Overath","year":"1999","journal-title":"Parasitol Today"},{"issue":"5733","key":"B60","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1126\/science.1112680","article-title":"The genome of the kinetoplastid parasite, Leishmania major","volume":"309","author":"Ivens","year":"2005","journal-title":"Science"},{"issue":"10","key":"B61","doi-asserted-by":"publisher","first-page":"5823","DOI":"10.4049\/jimmunol.1100197","article-title":"Structural basis of specificity and cross-reactivity in T cell receptors specific for cytochrome c-I-E(k)","volume":"186","author":"Newell","year":"2011","journal-title":"J Immunol"},{"issue":"16","key":"B62","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1016\/j.vaccine.2007.01.033","article-title":"Mimotope vaccines for cancer immunotherapy","volume":"25","author":"Sharav","year":"2007","journal-title":"Vaccine"},{"key":"B63","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3389\/fimmu.2013.00429","article-title":"GILT: shaping the MHC class II-restricted peptidome and CD4 T cell-mediated immunity","volume":"4","author":"Hastings","year":"2013","journal-title":"Front Immunol"},{"issue":"4","key":"B64","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1172\/JCI72058","article-title":"Collective nitric oxide production provides tissue-wide immunity during Leishmania infection","volume":"124","author":"Olekhnovitch","year":"2014","journal-title":"J Clin Invest"},{"issue":"10","key":"B65","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1128\/IAI.67.10.5379-5385.1999","article-title":"Proteophosphoglycan, a major secreted product of intracellular Leishmania mexicana amastigotes, is a poor B-cell antigen and does not elicit a specific conventional CD4+ T-cell response","volume":"67","author":"Aebischer","year":"1999","journal-title":"Infect Immun"},{"issue":"2","key":"B66","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.molbiopara.2009.10.009","article-title":"Gel free analysis of the proteome of intracellular Leishmania mexicana","volume":"169","author":"Paape","year":"2010","journal-title":"Mol Biochem Parasitol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jprot.2013.04.021","article-title":"Moving from unsequenced to sequenced genome: reanalysis of the proteome of Leishmania donovani","volume":"97","author":"Nirujogi","year":"2014","journal-title":"J Proteomics"},{"issue":"7","key":"B68","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/j.1462-5822.2011.01593.x","article-title":"Quantitative proteome profiling informs on phenotypic traits that adapt Leishmania donovani for axenic and intracellular proliferation","volume":"13","author":"Pescher","year":"2011","journal-title":"Cell Microbiol"},{"issue":"9","key":"B69","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.jprot.2011.05.005","article-title":"Contribution of proteomics of Leishmania spp. to the understanding of differentiation, drug resistance mechanisms, vaccine and drug development","volume":"74","author":"Paape","year":"2011","journal-title":"J Proteomics"},{"key":"B70","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jprot.2013.01.011","article-title":"Proteome changes associated with Leishmania donovani promastigote adaptation to oxidative and nitrosative stresses","volume":"81","author":"Sardar","year":"2013","journal-title":"J Proteomics"},{"issue":"12","key":"B71","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.bbapap.2012.07.010","article-title":"Quantitative proteomic profiling of the promastigotes and the intracellular amastigotes of Leishmania donovani isolates identifies novel proteins having a role in Leishmania differentiation and intracellular survival","volume":"1824","author":"Biyani","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"B72","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jprot.2014.02.030","article-title":"A quantitative proteomic screen to identify potential drug resistance mechanism in alpha-difluoromethylornithine (DFMO) resistant Leishmania donovani","volume":"102","author":"Singh","year":"2014","journal-title":"J Proteomics"},{"key":"B73","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jprot.2013.03.012","article-title":"Exoproteome dynamics in Leishmania infantum","volume":"84","author":"Santarem","year":"2013","journal-title":"J Proteomics"},{"issue":"9","key":"B74","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1074\/mcp.M500061-MCP200","article-title":"Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein","volume":"4","author":"Ishihama","year":"2005","journal-title":"Mol Cell Proteomics"},{"issue":"1","key":"B75","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.immuni.2005.05.009","article-title":"The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance","volume":"23","author":"Lazarski","year":"2005","journal-title":"Immunity"},{"issue":"8","key":"B76","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1084\/jem.185.8.1403","article-title":"Enhanced intracellular dissociation of major histocompatibility complex class I-associated peptides: a mechanism for optimizing the spectrum of cell surface-presented cytotoxic T lymphocyte epitopes","volume":"185","author":"Sijts","year":"1997","journal-title":"J Exp Med"},{"issue":"22","key":"B77","doi-asserted-by":"publisher","first-page":"4502","DOI":"10.1016\/j.vaccine.2007.03.014","article-title":"DNA vaccination against the parasite enzyme gamma-glutamylcysteine synthetase confers protection against Leishmania donovani infection","volume":"25","author":"Carter","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"B78","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1645\/GE-2360.1","article-title":"Vaccination with recombinant Leishmania donovani gamma-glutamylcysteine synthetase fusion protein protects against L. donovani infection","volume":"96","author":"Henriquez","year":"2010","journal-title":"J Parasitol"},{"issue":"7","key":"B79","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.vaccine.2011.12.067","article-title":"Comparative assessment of a DNA and protein Leishmania donovani gamma glutamyl cysteine synthetase vaccine to cross-protect against murine cutaneous leishmaniasis caused by L. major or L. mexicana infection","volume":"30","author":"Campbell","year":"2012","journal-title":"Vaccine"},{"issue":"10","key":"B80","doi-asserted-by":"publisher","first-page":"5637","DOI":"10.4049\/jimmunol.165.10.5637","article-title":"Priming by microbial antigens from the intestinal flora determines the ability of CD4+ T cells to rapidly secrete IL-4 in BALB\/c mice infected with Leishmania major","volume":"165","author":"Julia","year":"2000","journal-title":"J Immunol"},{"issue":"12","key":"B81","doi-asserted-by":"publisher","first-page":"e1406","DOI":"10.1371\/journal.pntd.0001406","article-title":"Single dose novel Salmonella vaccine enhances resistance against visceralizing L. major and L. donovani infection in susceptible BALB\/c mice","volume":"5","author":"Schroeder","year":"2011","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T04:31:29Z","timestamp":1689309089000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2014.00260\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,10]]},"references-count":81,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2014.00260","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,10]]}}}